Global Blood Therapeutics, Inc. Free Cash Flow 2015-2022 | GBT
Global Blood Therapeutics, Inc. free cash flow from 2015 to 2022. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| Global Blood Therapeutics, Inc. Annual Free Cash Flow |
| 2021 |
-260.05 |
| 2020 |
-220.62 |
| 2019 |
-197.83 |
| 2018 |
-140.12 |
| 2017 |
-96.12 |
| 2016 |
-69.08 |
| 2015 |
-31.88 |
| 2014 |
-20.44 |
| 2013 |
-15.64 |
| Global Blood Therapeutics, Inc. Quarterly Free Cash Flow |
| 2022-06-30 |
-116.80 |
| 2022-03-31 |
-72.11 |
| 2021-12-31 |
-260.05 |
| 2021-09-30 |
-191.07 |
| 2021-06-30 |
-125.50 |
| 2021-03-31 |
-80.39 |
| 2020-12-31 |
-220.62 |
| 2020-09-30 |
-170.99 |
| 2020-06-30 |
-130.02 |
| 2020-03-31 |
-81.15 |
| 2019-12-31 |
-197.83 |
| 2019-09-30 |
-133.28 |
| 2019-06-30 |
-78.80 |
| 2019-03-31 |
-40.37 |
| 2018-12-31 |
-140.12 |
| 2018-09-30 |
-106.75 |
| 2018-06-30 |
-74.20 |
| 2018-03-31 |
-37.27 |
| 2017-12-31 |
-96.12 |
| 2017-09-30 |
-69.44 |
| 2017-06-30 |
-42.63 |
| 2017-03-31 |
-22.75 |
| 2016-12-31 |
-69.08 |
| 2016-09-30 |
-48.78 |
| 2016-06-30 |
-29.82 |
| 2016-03-31 |
-15.01 |
| 2015-12-31 |
-31.88 |
| 2015-09-30 |
-22.02 |
| 2015-06-30 |
-12.96 |
| 2015-03-31 |
-6.23 |
| 2014-12-31 |
-20.44 |
| 2014-09-30 |
-14.95 |
| 2014-06-30 |
-9.83 |
| 2014-03-31 |
-4.30 |
